Skip to main content
Start of main content.

Sore throat and sinusitis, and the few benefits of antibiotics

An analysis of the evidence in the latest issue of Australian Prescriber suggests antibiotics have very few benefits for treating sore throat and acute sinusitis. Both conditions are common reasons for visits to the doctor.

Chris Del Mar, Professor of Public Health at Bond University, writes that because of the spectre of antibiotic resistance—something that is approaching a catastrophe—questions need to be asked about treatment of these conditions.

“The evidence shows that, in the case of antibiotics for sore throat and acute sinusitis, the benefits are marginal and antibiotic harms need to be factored in.”

Professor Del Mar says that as both sore throat and sinusitis get better on their own, three key questions should be asked:

  • Do antibiotics reduce the severity or duration of symptoms?
  • Do they reduce complications?
  • Do other interventions relieve symptoms?

“Evidence is accumulating that antibiotics deliver common harms, including rashes, diarrhoea and thrush. With antibiotic use, as well as the harms at the population level, individuals may carry antibiotic-resistant bacteria for up to 12 months following a course of antibiotics.”

Professor Del Mar says that it’s time to move on from many long-held beliefs on antibiotic use. “It’s hard to appreciate that 100 years ago parents were afraid of ‘strep throat’, an infectious disease that could kill. Historically, sore throat was of greater concern for its complications, such as acute rheumatic fever, rather than its symptoms. Outside of indigenous populations, the risk of rheumatic fever is now low (one case in every 10 GP-practising lifetimes), and is a weak justification for antibiotic use.”

“A difficulty facing prescribers is that treatment options for sore throat and acute sinusitis are few. However, the illnesses regularly resolve without treatment and complications are rarely a problem.” Professor Del Mar suggests how to address the challenge of communicating these complexities to patients and their parents.

To read the full article and others visit

More from Bond

  • Bull Sharks out to tame the Tigers

    The Bull Sharks have announced their 2023 captains as rugby returns to The Canal for the first time this year.

    Read article
  • International students join soccer goal rush

    Bond's soccer club have scored 49 times in three games as international students join the goal rush.

    Read article
  • Sapphires and Rubies glitter at Netball season launch

    The excitement was building at the Bull Sharks' season launch ahead of their return to the Sapphire Series

    Read article
  • Trouble brewing on geographical beer names

    Australian craft beer breweries could be caught up in a push by European brewers to protect the names of beer styles in the same way French winemakers jealously guard Champagne and Bordeaux.

    Read article
  • $1m to study diabetes patients left to their own devices

    A Bond University researcher has received more than $1 million to determine if wearable devices can help type 2 diabetes patients better manage their condition.

    Read article
Previous Next